01
Initial consultation
The clinician reviews weight history, BMI, health conditions, medicines, pregnancy plans and treatment goals. Important alternatives are also discussed.
NATURAL. SUBTLE. YOU.
Mounjaro Program
Mounjaro / Tirzepatide Program is a prescription
Duration30-60 mins
Results2-4 Weeks
Extremely safeDoctor-led
Price:€199
Treatment Duration:30-60 mins
Anaesthesia:Local
Results Visible:2-4 Weeks
Used product:Mounjaro
Pain level (0 - 10):2-3
Price:€199
Treatment Duration:30-60 mins
Anaesthesia:Local
Results Visible:2-4 Weeks
Used product:Mounjaro
Pain level (0 - 10):2-3
The goal is to support medically appropriate weight loss and weight maintenance alongside nutrition and physical activity with gradual dose adjustment and ongoing safety monitoring. Progress is reviewed against agreed goals.
What is Mounjaro / Tirzepatide Program?
Mounjaro / Tirzepatide Program is a prescription weight-management program using once-weekly tirzepatide alongside nutrition, activity and medical follow-up. The plan is adjusted to the patient’s anatomy, concerns and realistic expectations.
When do you choose this treatment?
Consider this program when BMI and weight-related health risks meet prescribing criteria and lifestyle measures alone have not been enough. A consultation should confirm suitability, alternatives and realistic expectations.
Treatment process
Each appointment is planned around your anatomy, goals, and medical suitability.
02
Preparation for treatment
Suitable patients receive a prescription, injection training and a nutrition and activity plan. Comfort and protection are checked.
03
Mounjaro / Tirzepatide Program treatment
The medicine is injected once weekly and the dose is increased only according to the prescribed schedule and tolerance.
04
Result review
Weight, side effects, nutrition and relevant health markers are reviewed regularly. Warning signs and review timing are confirmed.
Before and aftercare
Before the treatment
Share all medicines and medical history, especially pancreatitis, gallbladder disease, severe digestive problems, diabetes treatment, pregnancy plans or a relevant thyroid cancer history.
After the treatment
Follow the prescribed dose, stay hydrated, eat smaller balanced meals and contact the clinician for persistent vomiting, severe abdominal pain or symptoms of low blood sugar. Urgent concerns should be reported promptly.
Results
2-4 Weeks Progress is assessed over several months rather than at a fixed final date. Benefits generally depend on continuing the prescribed treatment and lifestyle plan; weight regain can occur after stopping. Ongoing prescription review, dose adjustment and monitoring are required. Future timing follows clinical review.
Pricing
Exact treatment planning and pricing are confirmed during consultation.
Mounjaro / Tirzepatide ProgramPersonalized treatment plan
€199Book
Prices may vary depending on product, amount, and treatment combination.
Why Divine Medica >
The goal is to support medically appropriate weight loss and weight maintenance alongside nutrition and physical activity with gradual dose adjustment and ongoing safety monitoring. Progress is reviewed against agreed goals.
- Premium, clinically tested products selected for medical suitability
- Treatment planning based on your wishes, symmetry, and facial features
- Natural-looking results with precise product placement
- Minimal downtime for most patients
- Guided aftercare to support healing and recovery
- Combination options after professional consultation
Personal consultation
Confirm that the patient meets current prescribing criteria, check contraindications and interactions, and review the official product information at each dose decision.
Make an Appointment >Divine Medica specialists >
Aesthetic medicine
Dr. med. Darko Nikolic
Specialist physician focused on personal consultation, medical responsibility and balanced treatment planning.
View Details →Aesthetic Medicine & Ophthalmology
Dr. med. Elizabeta Prendjova Nikolic
Specialist physician providing individual medical care with attention to safety, proportion and patient goals.
View Details →
Practice management
Seher Künstner
Head of Medical Cosmetics & Aesthetic Technologies with a focus on skin analysis, individual goals and long-term treatment planning.
View Details →
Virtual Clinic tour
Safety of Mounjaro
This is a prescription medical program and requires eligibility screening, review of other medicines and monitoring for important side effects. The clinic must maintain appropriate complication-management and emergency procedures. Clear informed consent remains essential.
Treatment highlights
Downtime and swelling
There is usually no procedural downtime. Swelling is not expected, although a mild injection-site reaction can occur. Most people can return to normal activities once comfortable and aftercare restrictions permit.
Common side effects
Nausea, diarrhoea, constipation, vomiting, reduced appetite, indigestion and abdominal discomfort are common. These effects are usually temporary.
Combination options
The program should be combined with nutrition, physical activity and management of sleep, stress and weight-related conditions.
Frequently
asked
questions ›
Find direct answers about Mounjaro / Tirzepatide Program, suitability, results, and aftercare.
Mounjaro / Tirzepatide Program is a prescription weight-management program using once-weekly tirzepatide alongside nutrition, activity and medical follow-up. The plan is adjusted to the patient’s anatomy, concerns and realistic expectations.
The first assessment usually takes 30-60 minutes, with shorter follow-up visits during ongoing treatment. Appetite and weight may begin to change within the first few weeks, but response varies. Progress is assessed over several months rather than at a fixed final date. Benefits generally depend on continuing the prescribed treatment and lifestyle plan; weight regain can occur after stopping. Ongoing prescription review, dose adjustment and monitoring are required. Future timing follows clinical review.
Discomfort is usually rated around 2-3 out of 10, although each person's experience can differ. No anaesthesia is required for the small under-the-skin injection. There is usually no procedural downtime. Swelling is not expected, although a mild injection-site reaction can occur. Nausea, diarrhoea, constipation, vomiting, reduced appetite, indigestion and abdominal discomfort are common. These effects are usually temporary.
Consider this program when BMI and weight-related health risks meet prescribing criteria and lifestyle measures alone have not been enough. A consultation should confirm suitability, alternatives and realistic expectations. This is a prescription medical program and requires eligibility screening, review of other medicines and monitoring for important side effects. The clinic must maintain appropriate complication-management and emergency procedures. Clear informed consent remains essential. Share all medicines and medical history, especially pancreatitis, gallbladder disease, severe digestive problems, diabetes treatment, pregnancy plans or a relevant thyroid cancer history. Follow the prescribed dose, stay hydrated, eat smaller balanced meals and contact the clinician for persistent vomiting, severe abdominal pain or symptoms of low blood sugar. Urgent concerns should be reported promptly.
